Academy of Nutrition and Dietetics Nutrition Practice Guideline for Type 1 and Type 2 Diabetes in Adults: Nutrition Intervention Evidence Reviews and Recommendations

Journal of the Academy of Nutrition and Dietetics

Volumn 117, Issue 10, 2017, Pages 1637-1658

  MacLeod, Janice ^a   Franz, Marion J ^a   Handu, Deepa ^a   Gradwell, Erica ^a   Brown, Catherine ^a   Evert, Alison ^a   Reppert, Adam ^a   Robinson, Megan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NUTRITIVE SWEETENER;

ADMINISTRATION AND DOSAGE; ADULT; BODY WEIGHT; CARBOHYDRATE DIET; DIET; DIET THERAPY; DIETETICS; EVIDENCE BASED MEDICINE; FAT INTAKE; GLYCEMIC INDEX; GLYCEMIC LOAD; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION POLICY; OBESITY; OBSERVATIONAL STUDY; ORGANIZATION; PRACTICE GUIDELINE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

ACADEMIES AND INSTITUTES; ADULT; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; DIETETICS; EVIDENCE-BASED MEDICINE; GLYCEMIC INDEX; GLYCEMIC LOAD; HUMANS; META-ANALYSIS AS TOPIC; NUTRITION POLICY; NUTRITIVE SWEETENERS; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; OVERWEIGHT; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85020080370     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2017.03.023     Document Type: Article

References (87)

1. Franz, M.J., MacLeod, J., Evert, A., et al. Academy of Nutrition and Dietetics Nutrition Practice Guideline for type 1 and type 2 diabetes in adults: Systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet 117:10 (2017), 1659–1679.
2. Academy of Nutrition and Dietetics diabetes type 1 and 2 evidence-based nutrition practice guideline for adults, 2015. Academy of Nutrition and Dietetics Evidence Analysis Library. http://www.andeal.org/topic.cfm?menu=5305. Accessed February 6, 2016.
3. American Dietetic Association diabetes type 1 and 2 evidence-based nutrition practice guideline for adults, 2008. American Dietetic Association Evidence Analysis Library. http://www.adaevidencelibrary.com/topic.cfm?=3252. Accessed April 10, 2017.
4. Franz, M.J., Powers, M.A., Leontos, C., et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc 110:12 (2010), 1852–1889.
5. Evert, A.B., Boucher, J.L., Cypress, M., et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 36:11 (2013), 3821–3842.
6. American Diabetes Association: Standards of medical care in diabetes—2017. Diabetes Care 40:suppl 1 (2017), S4–S127.
7. Handu, D., Moloney, L., Wolfram, T., Ziegler, P., Acosta, A., Steiber, A., Academy of Nutrition and Dietetics methodology for conducting systematic reviews for the Evidence Analysis Library. J Acad Nutr Diet 116:2 (2016), 311–318.
8. Raal, F.J., Kalk, W.J., Lawson, M., et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: A 6 month prospective study. Am J Clin Nutr 60:4 (1994), 579–585.
9. Hansen, H.P., Tauber-Lassen, E., Jense, B.R., Parving, H.H., Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 61:1 (2002), 220–228.
10. Robertson, L., Waugh, N., Robertson, A., Protein restriction for diabetic renal disease. Cochrane Database Syst Rev, 4, 2007, CD002181.
11. Velazquez, L.L., Sil, A.M.J., Goycochea, R.M.V., Torres, T.M., Castaneda, L.R., Effect of protein restriction diet on renal function and metabolic control in patients with type 2 diabetes: A randomized clinical trial. Nutr Hosp 23:2 (2008), 141–147.
12. Wolever, T.S.M., Gibbs, A.L., Mehlin, C., et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic index dietary carbohydrate in type 2 diabetes: No effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 87:1 (2008), 114–125.
13. Strychar, I.S., Cohn, J.S., Renier, G., et al. Effects of a diet higher in carbohydrate/lower in fat versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride concentrations and other cardiovascular risk factors in type 1 diabetes. Diabetes Care 32:9 (2009), 1597–1599.
14. Delahanty, L.M., Nathan, D.M., Lachin, J.M., et al. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr 89:2 (2009), 518–524.
15. van Wyk, H.J., Davis, R.E., Davies, J.S., A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med 33:2 (2016), 148–157.
16. Rock, C.L., Flatt, S.W., Pakiz, B., et al. Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: A randomized controlled trial. Diabetes Care 37:6 (2014), 1573–1580.
17. Yamada, Y., Uchida, J., Izumi, H., et al. A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetes. Intern Med 53:11 (2014), 13–19.
18. Tay, J., Luscombe-Marsh, N.D., Thompson, C.H., et al. Comparison of low-and high-carbohydrate diets for type 2 diabetes management: A randomized trial. Am J Clin Nutr 102:4 (2015), 780–790.
19. Moosheer, S.M., Waldschutz, W., Itariu, B.K., Brath, H., Stulnig, T.M., A protein-enriched low glycemic-index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Primary Care Diabet 8:4 (2014), 308–314.
20. England, C.Y., Thompson, J.L., Jago, R., Cooper, A.R., Andrews, R.C., Dietary changes and associations with metabolic improvements in adults with type 2 diabetes during a patient-centered dietary intervention: An exploratory analysis. BMJ Open, 4(6), 2014, e004953.
21. Vitale, M., Masulli, M., Rivellese, A.A., et al. Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study. Eur J Nutr 55:4 (2016), 1645–1651.
22. Tobias, D.K., Chen, M., Manson, J.E., Ludwig, D.S., Willet, W., Hu, F.B., Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 3:12 (2015), 968–979.
23. Vitolins, M.Z., Anderson, A.M., Delahanty, L., et al. Action for Health in Diabetes (Look AHEAD) Trial: Baseline evaluation of selected nutrients and food group intake. J Am Diet Assoc 109:8 (2009), 1367–1375.
24. Oza-Frank, R., Cheng, Y.J., Narayan, K.M., Gregg, E.W., Trends in nutrient intake among adults with diabetes in the United States: 1988-2004. J Am Diet Assoc 109:7 (2009), 1173–1178.
25. Eeley, E.A., Stratton, I.M., Hadden, D.R., Turner, R.C., Holman, R.R., UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group. Diabet Med 13:7 (1996), 656–662.
26. Krebs, J.D., Elley, C.R., Parry-Strong, A., et al. The Diabetes Excess Weight Loss (DEWL) Trial: A randomized controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 55:4 (2012), 905–914.
27. Iqbal, N., Vetter, M.L., Moore, R.H., et al. Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic patients. Obesity 18:9 (2010), 1733–1738.
28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:14 (1993), 977–986.
29. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:7367 (2002), 746–751.
30. Bergenstal, R.M., Johnson, M., Powers, M.A., et al. Adjust to target in type 2 diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 31:17 (2008), 1305–1310.
31. Franc, S., Dardari, D., Boucherie, B., et al. Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients. Diabetes Metab 35:6 (2009), 463–468.
32. Speight, J., Amiel, S.A., Bradley, C., et al. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment for Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes. Diabetes Res Clin Pract 89:1 (2010), 22–29.
33. Laurenzi, A., Bolla, A.M., Panigoni, G., et al. Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion (GIOCAR). Diabetes Care 34:4 (2011), 823–827.
34. Trento, M., Trinetta, A., Kucich, C., et al. Carbohydrate counting improves coping ability and metabolic control in patients with type 1 diabetes managed by Group Care. J Endocrinol Invest 34:2 (2011), 101–105.
35. Rankin, D., Cooke, D.D., Elliott, J., Heller, S.R., Lawton, J., UK NIHR DAFNE Study Group. Supporting self-management after attending a structured education programme: A qualitative longitudinal investigation of type 1 diabetes patients’ experiences and views. BMC Public Health, 12, 2012, 652.
36. Schmidt, S., Schelde, B., Norgaard, K., Effects of advanced carbohydrate counting in patients with Type 1 diabetes: A systematic review. Diabet Med 31:8 (2014), 886–896.
37. Bell, K.J., Smart, C.E., Steil, G.M., Brand-Miller, J.C., King, B., Wolpert, H.A., Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: Implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care 38:6 (2015), 1008–1015.
38. Paterson, M.A., Smart, C.E., Lopez, P.E., et al. Influence of dietary protein on postprandial blood glucose levels in individuals with type 1 diabetes mellitus using intensive insulin therapy. Diabet Med 33:5 (2016), 592–598.
39. McCulloch, D.K., Mitchell, R.D., Ambler, J., Tattersall, R.B., A prospective comparison of “conventional” and high carbohydrate/high fibre/low fat diets in adults with established type 1 (insulin-dependent) diabetes. Diabetologia 28:4 (1985), 208–212.
40. Milne, R.M., Mann, J.I., Chisholm, A.W., Williams, S.M., Long-term comparison of three dietary prescriptions in the treatment of NIDDM. Diabetes Care 17:1 (1994), 74–80.
41. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. 2002, The National Academies Press, Washington, DC.
42. Dietary Guidelines Advisory Committee (DGAC) Report on the Dietary Guidelines for Americans, 2015. http://health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietary-guidelines-advisory-committee.pdf. Accessed January 22, 2016.
43. Academy of Nutrition and Dietetics. Position of the Academy of Nutrition and Dietetics: Health implications of dietary fiber. J Acad Nutr Diet 115:11 (2015), 1861–1870.
44. Frost, G., Wilding, J., Beecham, J., Dietary advice based on the glycemic index improves dietary profile and metabolic control in type 2 diabetic patients. Diabet Med 11:4 (1994), 397–401.
45. Cheong, S.H., McCargar, L.J., Paty, B.W., Tudor-Locke, C., Bell, R.C., The First Step First Bite Program: Guidance to increase physical activity and daily intake of low-glycemic index foods. J Am Diet Assoc 109:8 (2009), 1411–1416.
46. Holub, I., Gostner, A., Hessdorfer, S., et al. Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus. Horm Metab Res 41:12 (2009), 886–892.
47. Turner-McGrievy, G.M., Jenkins, D.J., Barnard, N.D., Cohen, J., Gloede, L., Green, A.A., Decreases in dietary glycemic index are related to weight loss among individuals following therapeutic diets for type 2 diabetes. J Nutr 141:18 (2011), 1469–1474.
48. Jenkins, D.J.A., Vuksan, V., Augustin, L.S.A., et al. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: A randomized controlled trial. Diabetes Care 37:7 (2014), 1806–1814.
49. Wang, M.L., Gellar, L., Nathanson, B.H., et al. Decrease in glycemic index associated with improved glycemic control among Latinos with type 2 diabetes. J Acad Nutr Diet 115:6 (2015), 898–906.
50. Campbell, M.D., Gonzalez, J.T., Rumbold, P.L.S., et al. Comparison of appetite responses to high- and low-glycemic index post-exercise meals under matched insulinemia and fiber in type 1 diabetes. Am J Clin Nutr 101:3 (2015), 478–486.
51. Campbell, M.D., Walker, M., Trenell, M.I., et al. A Low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1. Diabetes Care 37:7 (2014), 1845–1853.
52. Franz, M.J., Boucher, J.L., Evert, A.B., Evidence-based diabetes nutrition therapy recommendations are effective: The key is individualization. Diabet Metab Syndr Obes 14:7 (2014), 65–72.
53. Buysschaert, M., Sory, R., Mpoy, M., Lambert, A.E., Effect of the addition of simple sugars to mixed meals on the glycemic control of insulin treated diabetic patients. Diabet Metab 13:6 (1987), 625–629.
54. Nadeau, J., Koski, K.G., Strychar, I., Yale, J.F., Teaching subjects with type 2 diabetes how to incorporate sugar choices into their daily meal plan promotes dietary compliance and does not deteriorate metabolic profile. Diabetes Care 24:2 (2001), 222–227.
55. Brunner, S., Holub, I., Theis, S., et al. Metabolic effects of replacing sucrose by isomaltulose in subjects with type 2 diabetes: A randomized double-blind trial. Diabetes Care 35:6 (2012), 1249–1251.
56. Fitch, C., Keim, K.S., Academy of Nutrition and Dietetics. Position of The Academy of Nutrition and Dietetics: Use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet 112:5 (2012), 739–758.
57. Ang, M., Linn, T., Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: A randomized trial. Am J Clin Nutr 100:4 (2014), 1059–1068.
58. Keyhani-Nejad, F., Kemper, M., Schueler, R., Pivovarova, O., Rudovich, N., Pfeiffer, A.F.H., Effects of palatinose and sucrose intake on glucose metabolism and incretin secretion in subjects with type 2 diabetes. Diabetes Care 39:3 (2016), e38–e39.
59. Rulis, A.M., Levitt, J.A., FDA's food ingredient approval process: Safety assurance based on scientific assessment. Regul Toxicol Pharmacol 53:1 (2009), 20–31.
60. Nehrling, J.K., Kobe, P., McLane, M.P., Olson, R.E., Kamath, S., Horwitz, D.L., Aspartame use by persons with diabetes. Diabetes Care 8:5 (1985), 415–417.
61. Grotz, V.L., Henry, R.R., McGill, J.B., Prince, M.J., Shamoon, H., Trout, J.R., Pi-Sunyer, F.X., Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 103:12 (2003), 1607–1612.
62. Maki, K.C., Curry, L.L., Reeves, M.S., et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 46:suppl 7 (2008), S47–S53.
63. Yarmolinsky, J., Duncan, B.B., Chambless, L.E., et al. Artificially sweetened beverage consumption is positively associated with newly diagnosed diabetes in normal-weight but not in overweight or obese Brazilian adults. J Nutr 146:2 (2016), 290–297.
64. Miller, P.E., Perez, V., Low-calorie sweeteners and body weight and composition: A meta-analysis of randomized controlled trials and prospective cohort studies. Am J Clin Nutr 100:3 (2014), 765–777.
65. Bryant, C.E., Non-nutritive sweeteners: No class effect on the glycemic or appetite responses to ingested glucose. Eur J Clin Nutr 68:5 (2014), 629–631.
66. Azadbakht, L., Atabak, S., Esmaillzadeh, A., Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: A longitudinal randomized clinical trial. Diabetes Care 31:4 (2008), 648–654.
67. Heine, R.J., Mulder, C., Popp-Snijders, C., van der Meer, J., van der Veen, E.A., Linoleic-acid-enriched diet: Long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. Am J Clin Nutr 49:3 (1989), 448–456.
68. Dullaart, R.P., Beusekamp, B.J., Meijer, S., Hoogenberg, K., van Doormaal, J.J., Sluiter, W.J., Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion. Diabetologia 35:2 (1992), 165–172.
69. Tapsell, L.C., Owen, A., Gillen, L.J., et al. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27:12 (2004), 2777–2783.
70. Jenkins, D.J.A., Kendall, C.W.C., Banach, M.S., et al. Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care 34:8 (2011), 1706–1711.
71. Connor, W.E., Prince, M.J., Ullmann, D., et al. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann NY Acad Sci 683 (1993), 337–340.
72. Morgan, W.A., Raskin, P., Rosenstock, J., A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Diabetes Care 18:1 (1995), 83–86.
73. McManus, R.M., Jumpson, J., Finegood, D.T., Clandinin, M.T., Ryan, E.A., A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 19:15 (1996), 463–467.
74. Rossing, P., Hansen, B.V., Nielsen, F.S., Myrup, B., Holmer, G., Parving, H.H., Fish oil in diabetic nephropathy. Diabetes Care 19:11 (1996), 1214–1219.
75. Goh, Y.K., Jumpsen, J.A., Ryan, E.A., Clandinin, M.T., Effect of omega-3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia 40:1 (1997), 45–52.
76. Pan, A., Sun, J., Chen, Y., et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double blind, crossover trial. PLoS One, 2(11), 2007, e1, 148.
77. Holman, R.R., Paul, S., Farmer, A., et al. Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): A randomized controlled trial. Diabetologia 52:1 (2009), 50–59.
78. Wong, C.Y., Yiu, K.H., Li, S.W., et al. Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with type 2 diabetes mellitus. Diabet Med 27:1 (2010), 54–60.
79. Esposito, K., Maiiorino, M.I., Petrizzo, M., Bellastella, G., Giugiliano, D., The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: Follow-up of a randomized trial. Diabetes Care 37:7 (2014), 1824–1830.
80. Maiorino, M.I., Bellastella, G., Petrizzo, M., Scappaticcio, L., Giugliano, D., Esposito, K., Anti-inflammatory effect of Mediterranean diet in type 2 diabetes is durable: 8-year follow-up of a controlled trial. Diabetes Care 39:3 (2016), e44–e45.
81. Estruch, R., Ros, E., Salas-Salvadó J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368:14 (2013), 1279–1290.
82. A Physical Activity Toolkit for Registered Dietitians: Utilizing Resources of Exercise is Medicine, 2013, Academy of Nutrition and Dietetics, Chicago, IL.
83. Gepner, Y., Golan, R., Harman-Boehm, I., et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: A 2-year randomized, controlled trial. Ann Intern Med 163:8 (2015), 569–579.
84. Colberg, S.R., Sigal, R.J., Yardley, J.E., et al. Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care 39:11 (2016), 2065–2079.
85. Falconer, C.L., Page, A.S., Andrews, R.C., Cooper, A.R., The potential impact of displacing sedentary time in adults with type 2 diabetes. Med Sci Sports Exerc 47:10 (2015), 2070–2075.
86. Heden, T.D., Winn, N.C., Mari, A., et al. Post-dinner resistance exercise improves postprandial risk factors more effectively than pre-dinner resistance exercise in patients with type 2 diabetes. J Appl Physiol 118:5 (2015), 624–634.
87. Greenwood, D.A., Young, H.M., Quinn, C.C., Tele-health remote monitoring systematic review: Structured self-monitoring of blood glucose and impact on A1C. J Diabetes Sci Technol 8:2 (2014), 378–381.